AiCuris Anti-Infective Cures AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2006-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.aicuris.com
Clinical Trials
17
Active:5
Completed:7
Trial Phases
3 Phases
Phase 1:8
Phase 2:4
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Phase 1
8 (57.1%)Phase 2
4 (28.6%)Phase 3
2 (14.3%)Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2
- Conditions
- HSV
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Registration Number
- NCT05844436
Thorough QT/QTc of Pritelivir in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 64
- Registration Number
- NCT05671029
- Locations
- 🇬🇧
Richmond Pharmacology Ltd, London, United Kingdom
Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir
- First Posted Date
- 2022-08-24
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 16
- Registration Number
- NCT05513625
- Locations
- 🇺🇸
Medpace Clinical Pharmacology, Cincinnati, Ohio, United States
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 153
- Registration Number
- NCT03073967
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Metro Infectious Disease Consultants, LLC - Huntsville, Hunstville, Alabama, United States
🇺🇸University of South Alabama, Mobile, Alabama, United States
Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes
Phase 2
Completed
- Conditions
- Herpes Labialis
- Interventions
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 362
- Registration Number
- NCT02871492
- Prev
- 1
- 2
- Next
News
No news found